• Portfolio
    • Next Investors
    • Catalyst Hunter
    • Wise-Owl
    • Next Biotech
    • Emerge
  • Latest Articles
  • Weekenders
  • Quick Takes
  • Education
  • Trust

  • Portfolio
    • Next Investors
    • Catalyst Hunter
    • Wise-Owl
    • Next Biotech
    • Emerge
  • Latest Articles
  • Weekenders
  • Quick Takes
  • Education
  • Trust
  1. Home
  2. Baby Formula

Baby Formula

bioscience logo.png

Leading investment firm invests in new CSIRO health technology

Finfeed Archived Aug 08, 2019

The estimated present value of benefits from the CSIRO’s work is around $3.2 billion per year, so it's no surprise that the CSIRO and the rather astute BioScience Managers would eventually cross paths.

JAT company logo.png

Is JAT’s First $10M in Sales a Stepping Stone to the Trillion Dollar China Retail Market?

Next Investors Archived Oct 18, 2018

Everything is coming together for Jatenergy (ASX:JAT) as we head into the holiday season, with all roads leading to consistently increasing sales and revenues.

JAT company logo.png

Jatenergy increases sales to over $10 million

Finfeed Archived Oct 17, 2018

In releasing its September quarter result, a notable takeaway from Jatenergy (ASX:JAT) was the strong revenue growth generated during the period.

JAT company logo.png

Jatenergy provides update on Golden Koala production run

Finfeed Archived Oct 01, 2018

China-Australia cross-border specialist in Fast Moving Consumer Goods (FMCG) exports, Jatenergy (ASX:JAT) has published an update on its website regarding its subsidiary Golden Koala.

Get expert stock analysis direct in your inbox

Join Our
Mailing List

Footer

Portfolio

  • Next Investors
  • Wise Owl
  • Catalyst Hunter
  • Next Biotech
  • Emerge

Support

  • Contact Us
  • Trust Centre
  • How it Works
  • History
  • FAQ
  • Definitions
  • Archived Articles
  • Bottom Drawer Portfolio

Policies

  • Customer Notice
  • Disclosure Policy
  • Financial Services Guide
  • ESG Policy
  • Privacy Policy

Subscribe Next Investors

Daily write ups on small cap stocks we are invested in:


Next Investors

This material has been prepared by S3 Consortium Pty Ltd (trading as StocksDigital). S3 Consortium Pty Ltd is a Corporate Authorised Representative (CAR 000433913) of 62 Consulting Pty Limited (ABN 88 664 809 303) (AFSL 548573) (62C).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by 62C, Price, StocksDigital, any of their related body corporates or any other person. To the maximum extent possible, 62C, Price, StocksDigital, their related body corporates or any other person do not accept any liability for any statement in this material.


© 2026 nextinvestors.com | All rights reserved

Follow Us